Mind Medicine (MindMed) Inc N.MMED

Primary Symbol: MNMD Alternate Symbol(s): N.MMED.WA | N.MMED.WR | N.MMED.WS

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > Stock Price Pressure

<< Previous

Bullboard Posts

Next >>

Post by sollmgon Jun 05, 2024 10:24am

88 Views

Post# 36073083

Stock Price Pressure

I looked for news to try and find a reason for the price movement. Found nothing bad. Then looked at the shorts. 22% of the float short. looks like a bear attack. Also looked at the institutional holding chart. Very encouraging. Currently stands at 35,149,152 shares